Relationship between Angiotensin II, Vascular Endothelial Growth Factor, and Arteriosclerosis Obliterans

<table class="table-group" id="tab14"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">The name of the reagent</td><td class="align_center">Source of reagents</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Ang II</td><td class="align_center">Shenzhen New Industry Biomedical Engineering Co., Ltd.</td></tr><tr><td class="align_left">VEGF</td><td class="align_center">Beijing Jianping Jinxing Biotechnology Co., Ltd.</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Disease Markers

tab14

Table 14

Table 14: Relationship between Angiotensin II, Vascular Endothelial Growth Factor, and Arteriosclerosis Obliterans 